HB Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6M Sell
23,096
-2,967
-11% -$1.42M 0.06% 154
2026
Q1
$12.8M Sell
26,063
-2,663
-9% -$1.45M 0.08% 131
2025
Q4
$16.6M Buy
28,726
+1,304
+5% +$737K 0.11% 103
2025
Q3
$13.3M Buy
27,422
+3,465
+14% +$1.61M 0.09% 123
2025
Q2
$9.71M Sell
23,957
-4,204
-15% -$1.76M 0.08% 138
2025
Q1
$14M Buy
28,161
+15,134
+116% +$8.2M 0.12% 104
2024
Q4
$6.78M Buy
13,027
+256
+2% +$141K 0.07% 134
2024
Q3
$7.9M Buy
12,771
+1,210
+10% +$716K 0.08% 113
2024
Q2
$6.39M Buy
11,561
+1,649
+17% +$945K 0.07% 128
2024
Q1
$5.76M Buy
9,912
+1,255
+14% +$704K 0.07% 138
2023
Q4
$4.6M Buy
8,657
+1,420
+20% +$687K 0.07% 142
2023
Q3
$3.66M Buy
7,237
+243
+3% +$129K 0.06% 152
2023
Q2
$3.65M Sell
6,994
-396
-5% -$214K 0.06% 152
2023
Q1
$4.26M Buy
7,390
+233
+3% +$131K 0.07% 135
2022
Q4
$3.94M Buy
7,157
+1,978
+38% +$1.05M 0.07% 137
2022
Q3
$2.63M Buy
5,179
+81
+2% +$45.3K 0.06% 151
2022
Q2
$2.77M Buy
5,098
+840
+20% +$462K 0.06% 147
2022
Q1
$2.52M Buy
4,258
+579
+16% +$333K 0.05% 159
2021
Q4
$2.46M Buy
+3,679
New +$2.3M 0.05% 145

Other funds holding TMO

HB Wealth Management's TMO Position: Q2 2026 in Review

HB Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, selling an estimated $1.42M and leaving 23,096 shares worth $11.6M. The position accounts for 0.06% of the portfolio, ranked #154.

HB Wealth Management first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $16.6M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • HB Wealth Management held 23,096 shares of Thermo Fisher Scientific worth $11.6M as of Q2 2026.
  • HB Wealth Management sold 2,967 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.42M.
  • Thermo Fisher Scientific made up 0.06% of HB Wealth Management's portfolio in Q2 2026, its #154 holding.
  • HB Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • HB Wealth Management's Thermo Fisher Scientific position peaked at $16.6M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.